Woodcock A, et al. — This study compared the response of patients with symptomatic asthma who started a once-daily treatment regimen of combined fluticasone furoate and vilanterol to those who utilized usual care. Asthma control was better in the fluticasone furoate/vilanterol combination group vs in the usual care group with no increase in serious adverse events.